Magnesium sulphate at 30 to 34 weeks’ gestational age: neuroprotection trial (MAGENTA) - study protocol

Overview of attention for article published in BMC Pregnancy and Childbirth, April 2013

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (73rd percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 4 X users

googleplus: 1 Google+ user

Citations

dimensions_citation: 35 Dimensions

Readers on

mendeley: 159 Mendeley

Summary X Google+ Dimensions citations

So far, Altmetric has seen 5 X posts from 4 X users, with an upper bound of 5,268 followers.

@NICU_Musings Perhaps, but more information about 2 year outcomes (death/CP) expected in 2021 because Magenta trial (https://t.co/34fsbAd40m) expected to report then.

25 Aug 2020

Reply Repost Favourite

@rodwhunt Thanks! Participants are part of a large RCT led by Caroline Crowther that will report 2 year death/CP outcome; results expected 2021. RCT protocol here: https://t.co/34fsbAd40m

25 Aug 2020

Reply Repost Favourite

MgSO4 at 30 to 34 weeks’ gestational age: neuroprotection trial (MAGENTA) - http://t.co/KfEuXi9nKn

24 Oct 2013

Reply Repost Favourite

MgSO4 at 30 to 34 weeks’ gestational age: neuroprotection trial (MAGENTA) - http://t.co/KfEuXi9nKn

24 Oct 2013

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.